Origins of LifeJune 19, 2002Were the first macromolecules created on a primitive beach? In order for life to emerge both peptides and nucleic acids must have appeared under "prebiotic" conditions. Despite numerous efforts, the formation of these macromolecules without the help of modern synthetic reagents has not been achieved in a laboratory. Now for the first time researchers have proposed a mechanism by which the formation of peptides could have occurred under prebiotic conditions. Reporting their findings in the July issue of the SCI journal Polymer International, they describe a molecular engine mechanism which could have taken place on primitive beaches in the Hadean age. The molecular engine (the primary pump) relies on a reaction cycle made up of several successive steps, fed by amino acids, and fueled by NOx species. French researchers repeatedly cycled through the reaction steps using models of the primitive ocean, and each time peptides were formed, showing that the primary pump works at ambient temperatures and it continuously generates, elongates and complexifies sequential peptides.
Only a few of all the possible peptide sequences were formed, demonstrating that the primary pump should be able to select particular peptide sequences. Further, the primary pump should be able to drive the peptide pool towards homochirality through the amplifcation from a starting small enantiomeric excess. For the proposed mechanism to work it assumes that there was a buffered ocean, emerged land and a nitrosating atmosphere. The researchers show that the primitive Earth during the Hadean may have satisfied all these requirements. The Hadean began approximately 4.6 billion years ago with the creation of the Earth and ended 3.8 billion years ago. It was during the Hadean that the Earth surface cooled and solidified. The oldest terrestrial rocks are from this age and their chemical character demonstrates that a stable continental crust existed. Analysis has also shown that huge volumes of liquid water must have been available on the surface of the primitive Earth, and as the moon was already formed this would have tidal properties. According to lead researcher Auguste Commeyras, of the University of Montpellier, "The primary pump could have worked as soon as the pH of the oceans rose to 4-5. We consider it reasonable to postulate that the primitive ocean was initially acidic due to the presence of large amounts of CO2, and that its pH gradually increased to its current level through extraction of alkaline materials from reductive rocks." The most recent works on the primitive atmosphere of the Earth suggest that its main components were CO2 and N2. Calculations show that sufficient NOx would have been available to supply the primary pump and act as a driving force to the mechanism. "The role of NO in the metabolisms of current living organisms might be a remnant of such a prebiotic chemistry," said Commeyras. In conclusion Commeyras says, "Our primary pump scenario appears to be the first that is capable of supplying sequential peptides under realistic prebiotic conditions. Maintained out of thermodynamic equilibrium this system had the ability to recycle its reagents and to cause the products to evolve and increase in complexity. The emerging peptides would quickly have begun to act as catalysts, which may have helped the emergence of autoreplicant systems." John Wiley & Sons | |||||||||||||||||||||
|
Related Peptides News Articles Protein misprediction uncovered by new technique A new bioinformatics tool is capable of identifying and correcting abnormal, incomplete and mispredicted protein annotations in public databases. NIST membrane model may unlock secrets of early-stage Alzheimer's Researchers at the National Institute of Standards and Technology (NIST) and three collaborating institutions are using a new laboratory model of the membrane surrounding neurons in the brain to study how a protein long suspected of a role in early-stage Alzheimer's disease actually impairs a neuron's structure and function. A viral cloaking device Viruses achieve their definition of success when they can thrive without killing their host. Now, biologists Pamela Bjorkman and Zhiru Yang of the California Institute of Technology have uncovered how one such virus, prevalent in humans, evolved over time to hide from the immune system. Prenatal drinking, environmental enrichment: effects on neurotrophins are independent of each other Prenatal alcohol exposure may be particularly destructive for neurotrophins, a family of peptides that influence the growth, development and functional plasticity of the fetal brain. Scientists demonstrate means of reducing Alzheimer's-like plaques in fly brain Neuroscientists at Cold Spring Harbor Laboratory (CSHL) are part of a collaboration that has succeeded in demonstrating that overexpression of an enzyme in the brain can reduce telltale deposits causally linked with Alzheimer's disease. Toothpick: New molecular tag IDs bone and tooth minerals Enlisting an army of plant viruses to their cause, materials researchers at the National Institute of Standards and Technology (NIST) have identified a small biomolecule that binds specifically to one of the key crystal structures of the body-the calcium compound that is the basic building block of teeth and bone. With refinements, the researchers say, the new molecule can be a highly discriminating probe for a wide range of diagnostic and therapeutic applications related to bones and teeth. Novel hydrogel systems for dentin regeneration Dental caries, or tooth decay, continues to be the most prevalent infectious disease in the world, presenting significant public health challenges and socio-economic consequences. Researchers coat titanium with polymer to improve integration of joint replacements Research at the Georgia Institute of Technology shows that coating a titanium implant with a new biologically inspired material enhances tissue healing, improves bone growth around the implant and strengthens the attachment and integration of the implant to the bone. New study shows potential to treat or prevent viral cancers A new study, presented at the SNM 55th Annual Meeting, shows that radioimmunotherapy (RIT) targeting viral antigens offers a novel option to treat-or even prevent-many viral cancers by targeting cancer cells expressing viral antigens or infected cells before they convert into malignancy. A protein sequence associated with Huntington's disease may become life-saving vaccine component On June 10, 2008 the scientific journal "Vaccine" published a paper by the Massachusetts based biotech company Cure Lab, Inc., demonstrating that a protein sequence important in neurodegenerative Huntington's disease can be safely used as a new generation of vaccine adjuvants. More Peptides News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||